
Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
Introduction Epidermal growth factor receptor inhibitors (EGFRIs), such as erlotinib and gefitinib, are widely used in the treatment of non-small cell lung cancer (NSCLC) and other malignancies. Cutaneous toxicities associated with these agents are well …